SynbiCITE welcomes RebelBio to London
- Posted on 6 December, 2017
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itself. We run a crucible that transforms scientists into entrepreneurs.
On top of our cash investment, during the program, teams have access to a fully equipped biosafety level lab, co-working space, dedicated mentorship and the support of a network of RebelBio alumni, investors, corporates and press partners.
RebelBio is an SOSV Accelerator.
Apply here: https://goo.gl/iencnF
Share this article:
People also read
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...